Biotechnology
Sekisui Diagnostics Invests $1.9 million in Microbial Biopharma CDMO Business
LEXINGTON, Massachusetts, May 15, 2019 /PRNewswire/ -- Sekisui Diagnostics Enzyme business announces the completion of a newBioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a$1.9 million investment. This investment is part of a long-term investment strateg...
2019-05-15 03:11
2230
BGI Genomics and Pryzm Health Form Strategic Partnership to Advance Precision Public Health
SHENZHEN, China, May 14, 2019 /PRNewswire/ -- BGI Genomics and digital health start-up, Pryzm Health (Pryzm), signed a Memorandum of Understanding (MoU) today for collaboration to advance precision public health in Australia. With their complementary expertise and technology, BGI Genomics and Pr...
2019-05-14 17:04
4627
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
PALO ALTO, California and SINGAPORE, May 14, 2019 /PRNewswire/ -- At a ceremony inSingapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact single-room proton therapy system at Biopolis...
2019-05-14 12:15
9627
Brain imaging AI leader icometrix raises $18 million in new funding
Company's technology will transform care for patients with brain disorders and injuries LEUVEN, Belgium and GENEVA and BOSTON, May 14, 2019 /PRNewswire/ -- icometrix , the global expert in brain imaging Artificial Intelligence solutions, has raised$18 million through a partnership led by Forestay...
2019-05-14 08:00
3953
Frost & Sullivan Publishes Annual Update on BioLineRx
TEL AVIV, Israel, May 13, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure o...
2019-05-13 23:46
1187
MGI Announces US$200 Million in First Round Fundraising
SHENZHEN, China, May 13, 2019 /PRNewswire/ -- MGI, a subsidiary of BGI Group, has disclosed that its first round of fundraising exceededUS$200 million , the largest amount of capital raised in the genetic field inChina in 2018. Investors included well-known institutions such as CITIC Goldstone Cap...
2019-05-13 20:01
2605
Ally Bridge Group Leads Pulmonx's $65 Million Financing, Further Strengthening Its Global Medtech Franchise
HONG KONG, May 10, 2019 /PRNewswire/ -- Ally Bridge Group ("ABG"), a leading global life science investment group, announced today that it led an over-subscribed$65 million financing of Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies with its key p...
2019-05-10 10:05
3115
Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis
REHOVOT, Israel, May 9, 2019 /PRNewswire/ -- Pi-Cardia Ltd. (www.pi-cardia.net
2019-05-09 09:00
1928
Kazia calls for greater awareness of the most lethal women's disease in Australia
SYDNEY, May 8, 2019 /PRNewswire/ -- This World Ovarian Cancer Day, Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) calls for greater awareness of what is the most lethal women's disease in Australia. Every year, approximately 1,600 Australian women are...
2019-05-08 09:55
6350
Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100
PLYMOUTH MEETING, Pennsylvania, May 6, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that its lead Phase 3 product candidate, VGX-3100, has been granted an Advanced Therapy Medicinal Product Certificate for quality and non-clinical data. The procedure of certifi...
2019-05-06 21:00
1967
Frost & Sullivan Publishes Annual Update on Cellect
TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...
2019-05-06 18:11
859
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
SHANGHAI and SAN DIEGO, May 5, 2019 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced that it has acquired Pharmapace, Inc., a US-based clinical research services company with expertise of provid...
2019-05-06 07:50
2563
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 309 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 280 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Most Read
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
2999
Ferretti's Dazzling Presence at the 2024 Singapore Yachting Festival: Showcasing Evolving Trends in Luxury Yachting
2024-04-28 15:02
2966
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2965
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
2024-04-28 09:39
2848